Global Colonoscopy Bowel Preparation Drugs Market Size, Trends & Growth Opportunity, By Drug Type (Isomotic Agents (High-volume Polyethylene Glycol Preparations, Sulfate-free PEG-ELS, Low-volume PEG Preparations), Hypersosmotic Agents (Oral sodium Sulfate, Magnesium Citrate, Sodium Phosphate), Hyposmotic Agents, and Combination Agent), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
Global Colonoscopy Bowel Preparation Drugs Market
Global Colonoscopy Bowel Preparation Drugs Market was valued at USD 2,500.9 million in 2021 and is expected to reach USD 4,500.7 million by 2027, at a CAGR 7.22% from 2022-2027.
Colonoscopy is a type of screening test that is used for detection of colorectal cancer. It is dependent on pre pre-procedure which is called colonoscopy bowel preparation, in this cleansing of colon is done in the patient’s colonoscopy. 
Colonoscopy bowel preparation drugs are classified into various types such as Isomotic Agents, Hypersosmotic Agents, Hyposmotic Agents, and Combination Agents. It involves taking a laxative medication & restricting one’s diet to clear the colon of stool so that the doctor can clearly see any abnormal areas in one’s colon during the procedure.
Market Drivers
Increasing research & development activities is the key driving factor which is expected to propel the global colonoscopy bowel preparation drugs market growth. For instance, in December 2019, ColonaryConcepts had announced the Phase III clinical trial of its Edible Colonoscopy preparation for bowel cleansing. 
Furthermore, adoption of collaboration activities by key vendors will positively influence the market growth. Moreover, rising prevalence of colorectal cancer is expected to boost the market growth during this forecast period.
Market Restraints
However, occurrence of side effects like abdominal pain, abdominal swelling, nausea, and vomiting are the challenging factors which are expected to hinder the global colonoscopy bowel preparation market growth in future.
Market Segmentation
The Global Colonoscopy Bowel Preparation Drugs Market is segmented into drug type such as Isomotic Agents (High-volume Polyethylene Glycol Preparations, Sulfate-free PEG-ELS, Low-volume PEG Preparations), Hypersosmotic Agents (Oral sodium Sulfate, Magnesium Citrate, Sodium Phosphate), Hyposmotic Agents, and Combination Agent. 
Further, the market is segmented into distribution channels such as Hospital Pharmacies, Retail Pharmacies, and Others.
Regional Analysis
The Global Colonoscopy Bowel Preparation Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to register a robust revenue CAGR over the forecast period 2027 owing to the increasing rate of colorectal cancer in the American market. Industry key players are likely to adopt collaborations and acquisition tactics, propelling the market growth.
Whereas, the European region accounted for the largest revenue share, and the trend is expected to continue during the forecast period owing to significant companies using inorganic growth tactics.
Market Key Players
Various key players are discussed in this report such as Bayer AG, ColonaryConcepts, Bausch Health Companies Inc., Ferring B.V., Norgine B.V. KOREA PHARMA CO., LTD., Braintree, and Others.
For instance, in January 2019, Norgine B.V. & KOREA PHARMA CO., LTD., a major pharmaceutical producer in Korea, had obtained sole license and distribution rights for Korea, by which Korea Pharma marketed and dispersed Norgine's drug, PLENVU.
Market Taxonomy
By Drug Type
•        Isomotic Agents 
•        High-volume Polyethylene Glycol Preparations
•        Sulfate-free PEG-ELS
•        Low-volume PEG Preparations
•        Hypersosmotic Agents
•        Oral sodium Sulfate
•        Magnesium Citrate
•        Sodium Phosphate
•        Hyposmotic Agents
•        Combination Agent
By Distribution Channel
•        Hospital Pharmacies
•        Retail Pharmacies
•        Others
By Region
•        North America
•        Latin America
•        Europe
•        Asia Pacific
•        Middle East & Africa

Global Colonoscopy Bowel Preparation Drugs Market 
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Colonoscopy Bowel Preparation Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Colonoscopy Bowel Preparation Drugs Market, By Type
5.1 Y-o-Y Growth Comparison, By Type 
5.2 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type 
5.3 Global Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Type
5.3.1 Isomotic Agents
5.3.1.1 High-Volume Polyethylene Glycol Preparations
5.3.1.2 Sulfate-free-PEG-ELS
5.3.1.3 Low Volume PEG preparations
5.3.2 Hypersosmotic Agents
5.3.2.1 Oral Sodium Sulfate
5.3.2.2 Magnesium Citrate
5.3.2.3 Sodium Phosphate
5.3.3 Hyposmotic Agents
5.3.4 Combination Agents
6 Global Colonoscopy Bowel Preparation Drugs Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Application
6.3 Global Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Others
7 Global Colonoscopy Bowel Preparation Drugs Market, By Region
7.1 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Region
7.2 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Region
7.3 Global Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Region
8 North America Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 – 2027)
8.1 Introduction
8.2 North America Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type
8.3 North America Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application
8.4 North America Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
8.4.1 U. S
8.4.2 Canada
8.4.3 Mexico
9 Europe Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type 
9.3 Europe Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application 
9.4 Europe Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4 Rest of Europe
10 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type 
10.3 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application 
10.4 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
11 Latin America Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type 
11.3 Latin America Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application 
11.4 Latin America Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
11.4.1 Brazil
11.4.2 Rest of Latin America
12 Middle East Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type 
12.3 Middle East Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application 
12.4 Middle East Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
12.4.1 Saudi Arabia
12.4.2 UAE
12.4.3 Egypt
12.4.4 Kuwait
12.4.5 South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Bayer AG
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 ColonaryConcepts
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Bausch Health Companies Inc
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Ferring B.V
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Norgine B.V
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 KOREA PHARMA CO., LTD.
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Braintree
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies